Publication | Closed Access
Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer＇s disease
17
Citations
0
References
2013
Year
Neurodegenerative DiseasesAlzheimer's DiseasePharmacological StudyMedicineNeuroprotectionNeurologyPharmacotherapyPharmacologyAlzheimer＇s DiseaseHuperzine A
No additional data available for this publication yet. Check back later!